The largest database of trusted experimental protocols

Cd86 fitc clone gl1

Manufactured by Thermo Fisher Scientific
Sourced in United States

CD86-FITC (clone GL1) is a fluorescently-labeled monoclonal antibody that binds to the CD86 antigen. CD86 is a costimulatory molecule expressed on the surface of antigen-presenting cells and plays a role in T cell activation. This product can be used for flow cytometric analysis.

Automatically generated - may contain errors

2 protocols using cd86 fitc clone gl1

1

Immunostimulatory Effects of Photodynamic Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immunostimulatory effects of PDT were investigated by seeding 5 × 104 MC38 cells, 4 × 104 CT26 cells or 3.5 × 104 TC-1 cells in 24-well plates and 104 D1DCs in 96-well plates (Corning, Glendale, CA, USA). After overnight incubation at 37 °C and 5% CO2, the cancer cells were incubated with 300 pM AU-011 in culture medium for 4 h, and subsequently illuminated with 690 nm light at 400 mW/cm2 for 0.25, 2.5, or 25 J/cm2. As controls, cells were subjected to incubation with 300 pM AU-011 only, 690 nm light only or three freeze/thaw cycles at  − 20 °C (FT). Following this, the PDT-treated tumor cells were added to the D1DCs at a ratio of 20: 1 (tumor cell: D1DC) and incubated for 24 h at 37 °C and 5% CO2. Cells were then collected, stained with 0.5 µM DAPI (Sigma-Aldrich, Zwijndrecht, The Netherlands), CD86-FITC (clone GL1; Thermofisher, Landsmeer, The Netherlands) and anti-CD11c-PE (Clone HL3; BD Biosciences, New Jersey, USA) before analysis by flow cytometry on a Cytek Aurora 3-Laser flow cytometer. D1DC controls consisted of D1DCs in mono-culture, poly I:C at 1 µg/mL, 300 pM AU-011 directly incubated with D1DCs, or 300 pM AU-011 incubated with tumor cells added to D1DCs without treatment (dark toxicity).
+ Open protocol
+ Expand
2

Immunostimulatory Effects of PDT

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immunostimulatory effects of PDT were investigated by seeding 5 × 105 MC38CFP cells in 24-well plates and 104 D1DCs in 96-well plates (Corning, Glendale, CA, USA). After overnight incubation at 37 °C and 5% CO2, the cancer cells were incubated with the ZnPc-EVs with a ZnPc concentration calibrated at 4 µM for 4 h and treated with PDT or FT as described. The (dying) treated tumor cells were then added to the D1DCs at a ratio of 20: 1 (tumor cell: D1DC) and incubated for 24 h at 37 °C and 5% CO2. The cells were then collected, stained with 0.5 µM DAPI (Sigma-Aldrich, Zwijndrecht, The Netherlands), anti-CD11c-PE (Clone HL3, BD Biosciences, New Jersey, USA) and CD86-FITC (clone GL1, Thermofisher, Landsmeer, The Netherlands), and finally, analyzed by flow cytometry on a Cytek Aurora 3-Laser flow cytometer. Controls consisted of D1DCs in mono-culture (-), poly I:C at indicated concentration, ZnPc-EVs directly incubated with D1DCs, or ZnPc-EVs incubated with tumor cells added to D1DCs without PDT.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!